Trio whole-exome sequencing results identified a de novo heterozygous pathogenic mutation in the ACTG2 gene consistent with a diagnosis of MMIHS. This evidence concerns the gene ACTG2 and megacystis-microcolon-intestinal hypoperistalsis syndrome 1.